Antibodies, Assay Kits, Biology Cells, cDNA, Culture Cells, DNA, DNA Templates, Elisa Kits, Equipments, Exosomes, Gels, Isotypes, Medium & Serums, NATtrol, Panel, Reagents, Recombinant Proteins, Ria Kits, RNA, Test Kits, Vector & Virus

Learn at the synthesis of complement components by human kidney mesangial cells in culture. Assessment of cytokine effects.

Learn at the synthesis of complement components by human kidney mesangial cells in culture. Assessment of cytokine effects.
Posted by Frank

Cultivation of kidney mesangial cells (MC) is easily established and widely used. MCs produce several complementary regulatory proteins (C). We studied whether MC synthesized components C (C3, C5, C8). MC culture was established from the normal portion of nephrectomy for kidney cancer. After growing to a close meeting in RPMI / 17% FBS and resting 24 hours in RPMI / 0.5% FBS, MC stimulated up to 72 hours with IL-1β or IL-6 (10, 100, 1000 U / mL).

Both C5 and C8 detection by ELISA. While C3 is present in supernatant in basal conditions (15.5-107.6 ng / 10 (6) cells / 24 hours) in different MC lines. IL-1β regulates synthesis with 2.4-4.5 folds, while IL-6 does not show any effect. The c3 synthetic rate is cell 1.76 ng / 10 (6) under IL-1 stimulation versus basal level 0.37 ng / hour / 10 (6) cells. MC C3 production, especially induced by IL-1 may have pathogenetic relevance in glomerulonephritis.

Rooperol, cytokine synthesis inhibitors, reduces breathing explosions on leukocytes and human macrophies and mice.

Chemiluminescence enhanced by Luminol is measured in all fresh human blood, or human neutrophils are isolated from the blood of heparation, macrophages of alveolar humans and macrophages of alveolar rats which are stimulated with endotoxin bacteria (LPS). Esther TetraAceTate from Rooperol, a recatechol that shows anticoytokine activity, added to the cell simultaneously with LPS inhibiting the breathing explosion. The effective concentration of Rooperol is in the range of 1-10 mothers depending on the type of cell and in accordance with the inhibition of the production of nitrate oxide by macrophages of mice alveolar. Thus Roerol can reduce some effects of excessive phagocytic activity and inflammatory reactions but by extinguishing free radical production can also reduce resistance to bacterial infections.

Leptin increases survival and induces migration, degranulation, and synthesis of cytokines from human basophyl.

Basophils are the rarest leukocytes in human blood, but are now recognized as one of the most important immunomodulatory cells and the effector in allergic inflammation. Leptin, a member of the Cytokine IL-6 family, has a metabolic effect as an adipocine, and is also known to participate in the pathogenesis of inflammatory reactions. Because there is an epidemiological relationship between obesity and allergies, we examine whether the basophyl function is modified by leptin.

We found that the human basophyl expressed Leptin receptor (LEPR) at MRNA and surface protein levels, which was regulated by IL-33. Leptin exerts strong effects on several basophyl functions. This causes a strong migration response to human basophyl, potentially similar to the basophil-active kemokine. Also, Leptin increases the survival of human basophyl, even though its potential is less than IL-3. In addition, CD63, the marker of basophil activation is stated on the cell surface, regulated by leptin, the effect is neutralized by blocking LEPR.

Basophyl degranulation assessment and cytokine synthesis found that leptin shows a strong priming effect on human basophyl degranulation in response to FCεRI aggregation and induces Th2, but not the production of cytokines by cells. In short, these findings indicate that leptin may be the main molecule that mediates the effects of adipocytes in inflammatory cells such as basophiles by binding LEPR and activating cellular functions, which may worsen allergic inflammation.

Learn at the synthesis of complement components by human kidney mesangial cells in culture. Assessment of cytokine effects.

Cultivation of kidney mesangial cells (MC) is easily established and widely used. MCs produce several complementary regulatory proteins (C). We studied whether MC synthesized components C (C3, C5, C8). MC culture was established from the normal portion of nephrectomy for kidney cancer. After growing to a close meeting in RPMI / 17% FBS and resting 24 hours in RPMI / 0.5% FBS, MC stimulated up to 72 hours with IL-1β or IL-6 (10, 100, 1000 U / mL). Both C5 and C8 detection by ELISA.

While C3 is present in supernatant in basal conditions (15.5-107.6 ng / 10 (6) cells / 24 hours) in different MC lines. IL-1β regulates synthesis with 2.4-4.5 folds, while IL-6 does not show any effect. The c3 synthetic rate is cell 1.76 ng / 10 (6) under IL-1 stimulation versus basal level 0.37 ng / hour / 10 (6) cells. MC C3 production, especially induced by IL-1 may have pathogenetic relevance in glomerulonephritis.

Rooperol, cytokine synthesis inhibitors, reduces breathing explosions on leukocytes and human macrophies and mice.

Chemiluminescence enhanced by Luminol is measured in all fresh human blood, or human neutrophils are isolated from the blood of heparation, macrophages of alveolar humans and macrophages of alveolar rats which are stimulated with endotoxin bacteria (LPS). Esther TetraAceTate from Rooperol, a recatechol that shows anticoytokine activity, added to the cell simultaneously with LPS inhibiting the breathing explosion. The effective concentration of Rooperol is in the range of 1-10 mothers depending on the type of cell and in accordance with the inhibition of the production of nitrate oxide by macrophages of mice alveolar. Thus Roerol can reduce some effects of excessive phagocytic activity and inflammatory reactions but by extinguishing free radical production can also reduce resistance to bacterial infections.

Learn at the synthesis of complement components by human kidney mesangial cells in culture. Assessment of cytokine effects.

Leptin increases survival and induces migration, degranulation, and synthesis of cytokines from human basophyl.

Basophils are the rarest leukocytes in human blood, but are now recognized as one of the most important immunomodulatory cells and the effector in allergic inflammation. Leptin, a member of the Cytokine IL-6 family, has a metabolic effect as an adipocine, and is also known to participate in the pathogenesis of inflammatory reactions. Because there is an epidemiological relationship between obesity and allergies, we examine whether the basophyl function is modified by leptin. We found that the human basophyl expressed Leptin receptor (LEPR) at MRNA and surface protein levels, which was regulated by IL-33.

Leptin exerts strong effects on several basophyl functions. This causes a strong migration response to human basophyl, potentially similar to the basophil-active kemokine. Also, Leptin increases the survival of human basophyl, even though its potential is less than IL-3. In addition, CD63, the marker of basophil activation is stated on the cell surface, regulated by leptin, the effect is neutralized by blocking LEPR. Basophyl degranulation assessment and cytokine synthesis found that leptin shows a strong priming effect on human basophyl degranulation in response to FCεRI aggregation and induces Th2, but not the production of cytokines by cells.

Recombinant Human GS

P0309 100ug
EUR 626.83
Description: Recombinant Human protein for GS

Recombinant Human AR

P0503 100ug
EUR 626.83
Description: Recombinant Human protein for AR

Recombinant Human C6

P0510 100ug
EUR 626.83
Description: Recombinant Human protein for C6

TAGAP Recombinant Protein (Human) (Recombinant- Tag)

RP030880 100 ug Ask for price

TAGLN Recombinant Protein (Human) (Recombinant- Tag)

RP030883 100 ug Ask for price

TAGLN Recombinant Protein (Human) (Recombinant- Tag)

RP030886 100 ug Ask for price

TAGAP Recombinant Protein (Human) (Recombinant- Tag)

RP043930 100 ug Ask for price

Recombinant Human EGF

EPT004 10ug
EUR 23.4
Description: Recombinant Human Epidermal Growth Factor is produced by our E.coli expression system and the target gene encoding Asn971-Arg1023 is expressed.

Recombinant Human PTH

EPT146 50ug
EUR 353.4
Description: Recombinant Human Parathyroid Hormone is produced by our E.coli expression system and the target gene encoding Ser32-Gln115 is expressed.

Recombinant Human LIF

EPT153 10ug
EUR 119.4
Description: Recombinant Human Leukemia Inhibitory Factor is produced by our E.coli expression system and the target gene encoding Ser23-Phe202 is expressed.

Recombinant Human C3a

EPT178 50ug
EUR 353.4
Description: Recombinant Human Complement Component C3a is produced by our E.coli expression system and the target gene encoding Ser672-Arg748 is expressed.

Recombinant Human SCF

EPT201 50ug
EUR 209.4
Description: Recombinant Human Stem Cell Factor is produced by our E.coli expression system and the target gene encoding Glu26-Ala189 is expressed.

Recombinant Human PRL

CM10-10ug 10ug
EUR 169.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human PRL

CM10-1mg 1mg
EUR 2008.8
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human PRL

CM10-500ug 500ug
EUR 1423.2
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human PRL

CM10-50ug 50ug
EUR 363.6
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human BAD

7-04501 2µg Ask for price

Recombinant Human BAD

7-04502 5µg Ask for price

Recombinant Human BAD

7-04503 10µg Ask for price

Recombinant Human CD2

7-04717 2µg Ask for price

Recombinant Human CD2

7-04718 5µg Ask for price

Recombinant Human CD2

7-04719 10µg Ask for price

Recombinant Human CD9

7-04741 2µg Ask for price

Recombinant Human CD9

7-04742 5µg Ask for price

Recombinant Human CD9

7-04743 10µg Ask for price

Recombinant Human p53

7-05785 2µg Ask for price

Recombinant Human p53

7-05786 5µg Ask for price

Recombinant Human p53

7-05787 10µg Ask for price

Recombinant Human PRL

AP76222 1mg
EUR 2369

Recombinant Human NSE

HEENP-1402 5ug Ask for price

Recombinant Human PDI

HEENP-1601 100ug Ask for price

Recombinant Human EGF

HEGFP-0501 100ug Ask for price

Recombinant Human BNP

HEOPP-0211 100ug Ask for price

Recombinant Human C5a

HEOPP-0306 5ug Ask for price

Recombinant Human EPG

HEOPP-0503 5ug Ask for price

Recombinant Human LIF

HEOPP-1202 5ug Ask for price

Recombinant Human MIA

HEOPP-1301 5ug Ask for price

Recombinant Human MIF

HEOPP-1308 10ug Ask for price

Recombinant Human NOV

HEOPP-1407 5ug Ask for price

Recombinant Human OSM

HEOPP-1503 10ug Ask for price

Recombinant Human OPG

HEOPP-1506 10ug Ask for price

Recombinant Human PTN

HEOPP-1607 5ug Ask for price

Recombinant Human SCF

HEOPP-1902 10ug Ask for price

Recombinant Human SHH

HEOPP-1907 5ug Ask for price

Recombinant Human CD7

RP-924 2 ug
EUR 416.4

Recombinant human DBT

P2445 100ug Ask for price
Description: Recombinant protein for human DBT

Recombinant human MT4

P2447 100ug Ask for price
Description: Recombinant protein for human MT4

Recombinant human EDA

P1422 100ug Ask for price
Description: Recombinant protein for human EDA

Recombinant human ENG

P1433 100ug Ask for price
Description: Recombinant protein for human ENG

Recombinant human PXN

P1439 100ug Ask for price
Description: Recombinant protein for human PXN

Recombinant human FAS

P1464 100ug Ask for price
Description: Recombinant protein for human FAS

Recombinant human REL

P1479 100ug Ask for price
Description: Recombinant protein for human REL

Recombinant human MET

P1995 100ug Ask for price
Description: Recombinant protein for human MET

Recombinant human KIT

P1996 100ug Ask for price
Description: Recombinant protein for human KIT

Recombinant human TEC

P1997 100ug Ask for price
Description: Recombinant protein for human TEC

Recombinant human FRY

P2014 100ug Ask for price
Description: Recombinant protein for human FRY

Recombinant human VHL

P2120 100ug Ask for price
Description: Recombinant protein for human VHL

Recombinant human FEV

P2435 100ug Ask for price
Description: Recombinant protein for human FEV

Recombinant human GGN

P2440 100ug Ask for price
Description: Recombinant protein for human GGN

Recombinant human KLB

P2441 100ug Ask for price
Description: Recombinant protein for human KLB

Recombinant Human CRP

P0007 100ug
EUR 626.83
Description: Recombinant Human protein for CRP

Recombinant Human PCT

P0010 100ug
EUR 626.83
Description: Recombinant Human protein for PCT

Recombinant Human AND

P0015 100ug
EUR 626.83
Description: Recombinant Human protein for AND

Recombinant Human CKB

P0020-B 100ug
EUR 626.83
Description: Recombinant Human protein for CKB

Recombinant Human CKM

P0020-M 100ug
EUR 626.83
Description: Recombinant Human protein for CKM

Recombinant Human EPO

P0026 100ug
EUR 626.83
Description: Recombinant Human protein for EPO

Recombinant Human HE4

P0034 100ug
EUR 626.83
Description: Recombinant Human protein for HE4

Recombinant Human NSE

P0039 100ug
EUR 626.83
Description: Recombinant Human protein for NSE

Recombinant Human NNE

P0040 100ug
EUR 626.83
Description: Recombinant Human protein for NNE

Recombinant Human PSA

P0041 100ug
EUR 626.83
Description: Recombinant Human protein for PSA

Recombinant Human HE4

P0059 100ug
EUR 626.83
Description: Recombinant Human protein for HE4

Recombinant Human YY1

P0117 100ug
EUR 626.83
Description: Recombinant Human protein for YY1

Recombinant Human SAA

P0209 100ug
EUR 626.83
Description: Recombinant Human protein for SAA

Recombinant Human JNK

P0225 100ug
EUR 626.83
Description: Recombinant Human protein for JNK

Recombinant Human ECS

P0241 100ug
EUR 626.83
Description: Recombinant Human protein for ECS

Recombinant Human TBP

P0268 100ug
EUR 626.83
Description: Recombinant Human protein for TBP

Recombinant Human NPY

P0282 100ug
EUR 626.83
Description: Recombinant Human protein for NPY

Recombinant Human FYN

P0305 100ug
EUR 626.83
Description: Recombinant Human protein for FYN

Recombinant Human P65

P0336 100ug
EUR 626.83
Description: Recombinant Human protein for P65

Recombinant Human CBP

P0344 100ug
EUR 626.83
Description: Recombinant Human protein for CBP

Recombinant Human NIK

P0349 100ug
EUR 626.83
Description: Recombinant Human protein for NIK

Recombinant Human ADO

P0377 100ug
EUR 626.83
Description: Recombinant Human protein for ADO

Recombinant Human HK3

P0394 100ug
EUR 626.83
Description: Recombinant Human protein for HK3

Recombinant Human GLS

P0450 100ug
EUR 626.83
Description: Recombinant Human protein for GLS

Recombinant Human SRC

P0454 100ug
EUR 626.83
Description: Recombinant Human protein for SRC

Recombinant Human TAU

P0455 100ug
EUR 626.83
Description: Recombinant Human protein for TAU

Recombinant Human ME1

P0470 100ug
EUR 626.83
Description: Recombinant Human protein for ME1

Recombinant Human ADP

P0472 100ug
EUR 626.83
Description: Recombinant Human protein for ADP

Recombinant Human B2M

P0482 100ug
EUR 626.83
Description: Recombinant Human protein for B2M

Recombinant Human GLA

P0494 100ug
EUR 626.83
Description: Recombinant Human protein for GLA

Recombinant Human CAT

P0501 100ug
EUR 626.83
Description: Recombinant Human protein for CAT

Recombinant Human AFM

P0508 100ug
EUR 626.83
Description: Recombinant Human protein for AFM

Recombinant Human CA9

P0512 100ug
EUR 626.83
Description: Recombinant Human protein for CA9

Recombinant Human BAX

P0544 100ug
EUR 626.83
Description: Recombinant Human protein for BAX

Recombinant Human DAT

P0545 100ug
EUR 626.83
Description: Recombinant Human protein for DAT

Recombinant human DBH

P1000 100ug Ask for price
Description: Recombinant protein for human DBH

Recombinant human MIS

P1035 100ug Ask for price
Description: Recombinant protein for human MIS

Recombinant human SCX

P1063 100ug Ask for price
Description: Recombinant protein for human SCX

Recombinant human SON

P1072 100ug Ask for price
Description: Recombinant protein for human SON

Recombinant human FAN

P1140 100ug Ask for price
Description: Recombinant protein for human FAN

Recombinant human BI1

P1177 100ug Ask for price
Description: Recombinant protein for human BI1

Recombinant Human TNF-?

SJA03-03 25µg/vial
EUR 282

Recombinant Human TNF-?

SJA03-04 50µg/vial
EUR 342

Recombinant Human SCF

SJA06-01 10µg/vial
EUR 342

Recombinant Human SCF

SJA06-02 100µg/vial
EUR 846

Recombinant Human EGF

SJA08-01 100µg/vial
EUR 168

Recombinant Human IFN-?

SJC03-01 20µg/vial
EUR 228

Recombinant Human IFN-?

SJC03-02 100µg/vial
EUR 342

Recombinant Human EGF

Z100139 1.0 mg
EUR 205
Description: Epidermal growth factor (EGF) is a small mitogenic protein that is thought to be involved in mechanisms such as normal cell growth, oncogenesis, and wound healing. This protein shows both strong sequential and functional homology with human type-alpha transforming growth factor (hTGF alpha), which is a competitor for EGF receptor sites. EGF receptors are expressed in almost all types of tissues. Parietal endoderm, mature skeletal muscles, and hematopoietic tissues do not express the receptor. The EGF receptor, designated HER1, is a 170 kDa transmembrane glycoprotein with a length of 1186 amino acids. It is identical with a previously described glycoprotein called SA-7 (species antigen 7). The extracellular receptor domain has a length of 621 amino acids, including 11 glycosylated asparagine residues and 51 cysteine residues. This domain contains the EGF binding site and also binds mammalian TGF-alpha.

Recombinant Human GH1

Z100265 500 µg
EUR 85
Description: The physiological activity for which growth hormone is best known is the promotion of growth of bone, cartilage, and soft tissues. Detectable levels of growth hormone are found throughout the remainder of adulthood, suggesting other functions in addition to promotion of growth. Growth hormone may be important for the maintenance of lean body mass; most growth-promoting effects of growth hormone are mediated by IGF-1 the synthesis of which is regulated by growth hormone. The biological activities of growth hormone are mediated by receptors belonging to one of the cytokine receptor families. Growth hormone has been shown to be produced by T cells, B cells, and macrophages. In human lymphocytes growth hormone appears to up-regulate its own expression. Growth hormone appears to act as an enhancer of immune responses and is produced in considerable amounts by T helper cells.

Recombinant Human GH1

Z100269 1.0 mg
EUR 150
Description: The physiological activity for which growth hormone is best known is the promotion of growth of bone, cartilage, and soft tissues. Detectable levels of growth hormone are found throughout the remainder of adulthood, suggesting other functions in addition to promotion of growth. Growth hormone may be important for the maintenance of lean body mass; most growth-promoting effects of growth hormone are mediated by IGF-1 the synthesis of which is regulated by growth hormone. The biological activities of growth hormone are mediated by receptors belonging to one of the cytokine receptor families. Growth hormone has been shown to be produced by T cells, B cells, and macrophages. In human lymphocytes growth hormone appears to up-regulate its own expression. Growth hormone appears to act as an enhancer of immune responses and is produced in considerable amounts by T helper cells.

Recombinant Human IL2

Z100485 50 µg
EUR 85
Description: A helical bundle of 4 α-helices, IL2 is an immunoregulatory cytokine that is expressed by CD4+/CD8+ T cells, γδ T cells, B cells, eosinophils and dendritic cells. IL2 stimulates growth and differentiation of B-cells, NK cells, lymphokine-activated killer cells, monocytes, macrophages and oligodendrocytes. While Human IL2 shares 56% and 66% amino acid sequence identity with mouse and rat IL2, respectively only human and mouse IL2 exhibit cross-species activity. Characteristically, IL2 exerts both autocrine and paracrine activity on T cells. In a regulatory role, IL2 is important for the development, survival, and function of regulatory T cells, it enhances Fas-mediated activation-induced cell death, and it inhibits the development of inflammatory Th17 cells. Recombinant Human IL2 is a non-glycosylated polypeptide that contains one intrachain disulfide bond.

Recombinant Human IL2

Z100487 100 µg
EUR 145
Description: A helical bundle of 4 α-helices, IL2 is an immunoregulatory cytokine that is expressed by CD4+/CD8+ T cells, γδ T cells, B cells, eosinophils and dendritic cells. IL2 stimulates growth and differentiation of B-cells, NK cells, lymphokine-activated killer cells, monocytes, macrophages and oligodendrocytes. While Human IL2 shares 56% and 66% amino acid sequence identity with mouse and rat IL2, respectively only human and mouse IL2 exhibit cross-species activity. Characteristically, IL2 exerts both autocrine and paracrine activity on T cells. In a regulatory role, IL2 is important for the development, survival, and function of regulatory T cells, it enhances Fas-mediated activation-induced cell death, and it inhibits the development of inflammatory Th17 cells. Recombinant Human IL2 is a non-glycosylated polypeptide that contains one intrachain disulfide bond.

Recombinant Human IL2

Z100489 1.0 mg
EUR 615
Description: A helical bundle of 4 α-helices, IL2 is an immunoregulatory cytokine that is expressed by CD4+/CD8+ T cells, γδ T cells, B cells, eosinophils and dendritic cells. IL2 stimulates growth and differentiation of B-cells, NK cells, lymphokine-activated killer cells, monocytes, macrophages and oligodendrocytes. While Human IL2 shares 56% and 66% amino acid sequence identity with mouse and rat IL2, respectively only human and mouse IL2 exhibit cross-species activity. Characteristically, IL2 exerts both autocrine and paracrine activity on T cells. In a regulatory role, IL2 is important for the development, survival, and function of regulatory T cells, it enhances Fas-mediated activation-induced cell death, and it inhibits the development of inflammatory Th17 cells. Recombinant Human IL2 is a non-glycosylated polypeptide that contains one intrachain disulfide bond.

Recombinant Human IL3

Z100515 10 µg
EUR 85
Description: IL3 is produced mainly by T cells following cell activation by antigens and mitogens, but also by keratinocytes, natural killer cells, mast cells, endothelial cells, and monocytes. The analysis of bacterial- derived recombinant IL3 shows that glycosylation is not required for activity. IL3 sequences are evolutionarily less well conserved with human and murine IL3 sharing approximately 29% homology (at the protein level) and murine and rat IL3 sharing approximately 54% homology. IL3 receptors are expressed on macrophages, mast cells, eosinophils, megakaryocytes, basophils, bone marrow progenitor cells and various myeloid leukemia cells. Binding of IL3 to its receptor causes specific phosphorylation of a 150 kDa membrane glycoprotein. Recombinant human IL3 is a non-glycosylated globular protein.

Recombinant Human IL3

Z100517 50 µg
EUR 155
Description: IL3 is produced mainly by T cells following cell activation by antigens and mitogens, but also by keratinocytes, natural killer cells, mast cells, endothelial cells, and monocytes. The analysis of bacterial- derived recombinant IL3 shows that glycosylation is not required for activity. IL3 sequences are evolutionarily less well conserved with human and murine IL3 sharing approximately 29% homology (at the protein level) and murine and rat IL3 sharing approximately 54% homology. IL3 receptors are expressed on macrophages, mast cells, eosinophils, megakaryocytes, basophils, bone marrow progenitor cells and various myeloid leukemia cells. Binding of IL3 to its receptor causes specific phosphorylation of a 150 kDa membrane glycoprotein. Recombinant human IL3 is a non-glycosylated globular protein.

Recombinant Human IL3

Z100519 1.0 mg
EUR 2260
Description: IL3 is produced mainly by T cells following cell activation by antigens and mitogens, but also by keratinocytes, natural killer cells, mast cells, endothelial cells, and monocytes. The analysis of bacterial- derived recombinant IL3 shows that glycosylation is not required for activity. IL3 sequences are evolutionarily less well conserved with human and murine IL3 sharing approximately 29% homology (at the protein level) and murine and rat IL3 sharing approximately 54% homology. IL3 receptors are expressed on macrophages, mast cells, eosinophils, megakaryocytes, basophils, bone marrow progenitor cells and various myeloid leukemia cells. Binding of IL3 to its receptor causes specific phosphorylation of a 150 kDa membrane glycoprotein. Recombinant human IL3 is a non-glycosylated globular protein.

Recombinant Human IL4

Z100545 10 µg
EUR 60
Description: IL4 is produced mainly by a sub-population of activated T helper cells which also secrete IL5 and IL6. The biological activities of IL4 are mediated by a specific receptor, the extracellular domain of which is related to the receptors for EPO, IL6, and the beta chain of the IL-2 receptor. IL4 participates in several B-cell activation processes as well as of other cell types. A co-stimulator of DNA-synthesis, IL4 induces the expression of class II MHC molecules on resting B-cells, enhances both secretion and cell surface expression of IgE and IgG1, and also regulates the expression of the low affinity Fc receptor for IgE on both lymphocytes and monocytes. Pre-treatment of macrophages with IL4 prevents the production of IL1, TNF-alpha and prostaglandins in response to activation of the cells by bacterial endotoxins or IFN-gamma.

Recombinant Human IL4

Z100547 100 µg
EUR 470
Description: IL4 is produced mainly by a sub-population of activated T helper cells which also secrete IL5 and IL6. The biological activities of IL4 are mediated by a specific receptor, the extracellular domain of which is related to the receptors for EPO, IL6, and the beta chain of the IL-2 receptor. IL4 participates in several B-cell activation processes as well as of other cell types. A co-stimulator of DNA-synthesis, IL4 induces the expression of class II MHC molecules on resting B-cells, enhances both secretion and cell surface expression of IgE and IgG1, and also regulates the expression of the low affinity Fc receptor for IgE on both lymphocytes and monocytes. Pre-treatment of macrophages with IL4 prevents the production of IL1, TNF-alpha and prostaglandins in response to activation of the cells by bacterial endotoxins or IFN-gamma.

Recombinant Human IL4

Z100549 1.0 mg
EUR 3450
Description: IL4 is produced mainly by a sub-population of activated T helper cells which also secrete IL5 and IL6. The biological activities of IL4 are mediated by a specific receptor, the extracellular domain of which is related to the receptors for EPO, IL6, and the beta chain of the IL-2 receptor. IL4 participates in several B-cell activation processes as well as of other cell types. A co-stimulator of DNA-synthesis, IL4 induces the expression of class II MHC molecules on resting B-cells, enhances both secretion and cell surface expression of IgE and IgG1, and also regulates the expression of the low affinity Fc receptor for IgE on both lymphocytes and monocytes. Pre-treatment of macrophages with IL4 prevents the production of IL1, TNF-alpha and prostaglandins in response to activation of the cells by bacterial endotoxins or IFN-gamma.

Recombinant Human IL6

Z100555 20 µg
EUR 235
Description: IL6 is a pleiotropic cytokine that participates in a wide variety of biological functions such as acute phase response, inflammation, hematopoiesis, bone metabolism and cancer. While produced mainly by stimulated monocytes, fibroblasts and endothelial cells, IL6 is also known to be produced by macrophages, T cells, B lymphocytes, granulocytes, smooth muscle cells, eosinophils, chondrocytes, osteoblasts, mast cells, glial cells and keratinocytes, upon stimulation. Unlike murine IL6 which is inactive on human cells, both human and murine IL6 are equally active on murine cells. The IL6 receptor is a strongly glycosylated protein of 80 kDa and a length of 449 amino acids (designated CD126). Recombinant human IL6 is a 21 kDa, non-glycosylated protein that contains two disulfide bridges.

Recombinant Human IL6

Z100557 100 µg
EUR 960
Description: IL6 is a pleiotropic cytokine that participates in a wide variety of biological functions such as acute phase response, inflammation, hematopoiesis, bone metabolism and cancer. While produced mainly by stimulated monocytes, fibroblasts and endothelial cells, IL6 is also known to be produced by macrophages, T cells, B lymphocytes, granulocytes, smooth muscle cells, eosinophils, chondrocytes, osteoblasts, mast cells, glial cells and keratinocytes, upon stimulation. Unlike murine IL6 which is inactive on human cells, both human and murine IL6 are equally active on murine cells. The IL6 receptor is a strongly glycosylated protein of 80 kDa and a length of 449 amino acids (designated CD126). Recombinant human IL6 is a 21 kDa, non-glycosylated protein that contains two disulfide bridges.

Recombinant Human IL6

Z100559 10 x 100 µg (Z100557 x 10)
EUR 4215
Description: IL6 is a pleiotropic cytokine that participates in a wide variety of biological functions such as acute phase response, inflammation, hematopoiesis, bone metabolism and cancer. While produced mainly by stimulated monocytes, fibroblasts and endothelial cells, IL6 is also known to be produced by macrophages, T cells, B lymphocytes, granulocytes, smooth muscle cells, eosinophils, chondrocytes, osteoblasts, mast cells, glial cells and keratinocytes, upon stimulation. Unlike murine IL6 which is inactive on human cells, both human and murine IL6 are equally active on murine cells. The IL6 receptor is a strongly glycosylated protein of 80 kDa and a length of 449 amino acids (designated CD126). Recombinant human IL6 is a 21 kDa, non-glycosylated protein that contains two disulfide bridges.

Recombinant Human LIF

Z100605 10 µg
EUR 85
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130.

Recombinant Human LIF

Z100607 100 µg
EUR 360
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130.

Recombinant Human LIF

Z100609 1.0 mg
EUR 1500
Description: LIF is a multifunctional secreted glycoprotein that exists in both soluble and matrix bound forms. It displays biologic activities ranging from the differentiation of myeloid leukemic cells into macrophage lineage to effects on bone metabolism, inflammation, neural development, embryogenesis, and the maintenance of implantation. It is now clear that LIF is related in both structure and mechanism of action to the interleukin IL-6 family of cytokines, which also includes IL-11, ciliary neurotrophic factor, oncostatin M, and cardiotrophin 1. The actions of these cytokines are mediated through specific cell-surface receptors that consist of a unique chain and the shared signal transducing subunit gp130.

Recombinant Human OSM

Z100755 10 µg
EUR 85
Description: Oncostatin M is produced by monocytes and T cells after cell activation, adherent macrophages, and various T cell lines. Oncostatin M is a member of the IL-6-related cytokine subfamily that includes IL-6, IL-11, LIF, CNTF and CT-1. Oncostatin M mediates its bioactivities through two different heterodimer receptors. They both involve gp130 as a signal transducing moiety, which is found also in receptors for a number of other cytokines. When gp130 dimerizes with LIF receptor beta subunit this generates the high affinity type 1 OSM receptor. When gp130 dimerizes with a protein known as OSM receptor beta this generates the type 2 OSM receptor. Both OSM receptors activate the receptor-associated Janus kinases JAK1, JAK2, and TYK2. Signaling also involves the transcriptional activators STAT3 and STAT5b (see also: STAT proteins) were specifically activated through the gp130-OSM-R-beta type II heterocomplex. The signaling pathway differences observed between the common type I LIF/OSM receptor and the specific type II OSM receptor might explain some of the bioactivities specifically displayed by OSM. Oncostatin M inhibits the growth of several tumor cell lines (A375 melanoma, lung carcinomas). The antiproliferative activity of oncostatin M for some cell lines is synergised by TGF-beta and IFN-gamma. It promotes the growth of human fibroblasts, vascular smooth muscle cells, and some normal cell lines. Oncostatin can inhibit the proliferation of murine M1 myeloid leukemic cells and induces their differentiation into macrophage-like cells, a function shared by LIF, G- CSF, and IL-6.

Recombinant Human OSM

Z100757 200 µg
EUR 925
Description: Oncostatin M is produced by monocytes and T cells after cell activation, adherent macrophages, and various T cell lines. Oncostatin M is a member of the IL-6-related cytokine subfamily that includes IL-6, IL-11, LIF, CNTF and CT-1. Oncostatin M mediates its bioactivities through two different heterodimer receptors. They both involve gp130 as a signal transducing moiety, which is found also in receptors for a number of other cytokines. When gp130 dimerizes with LIF receptor beta subunit this generates the high affinity type 1 OSM receptor. When gp130 dimerizes with a protein known as OSM receptor beta this generates the type 2 OSM receptor. Both OSM receptors activate the receptor-associated Janus kinases JAK1, JAK2, and TYK2. Signaling also involves the transcriptional activators STAT3 and STAT5b (see also: STAT proteins) were specifically activated through the gp130-OSM-R-beta type II heterocomplex. The signaling pathway differences observed between the common type I LIF/OSM receptor and the specific type II OSM receptor might explain some of the bioactivities specifically displayed by OSM. Oncostatin M inhibits the growth of several tumor cell lines (A375 melanoma, lung carcinomas). The antiproliferative activity of oncostatin M for some cell lines is synergised by TGF-beta and IFN-gamma. It promotes the growth of human fibroblasts, vascular smooth muscle cells, and some normal cell lines. Oncostatin can inhibit the proliferation of murine M1 myeloid leukemic cells and induces their differentiation into macrophage-like cells, a function shared by LIF, G- CSF, and IL-6.

Recombinant Human OSM

Z100759 1.0 mg
EUR 2015
Description: Oncostatin M is produced by monocytes and T cells after cell activation, adherent macrophages, and various T cell lines. Oncostatin M is a member of the IL-6-related cytokine subfamily that includes IL-6, IL-11, LIF, CNTF and CT-1. Oncostatin M mediates its bioactivities through two different heterodimer receptors. They both involve gp130 as a signal transducing moiety, which is found also in receptors for a number of other cytokines. When gp130 dimerizes with LIF receptor beta subunit this generates the high affinity type 1 OSM receptor. When gp130 dimerizes with a protein known as OSM receptor beta this generates the type 2 OSM receptor. Both OSM receptors activate the receptor-associated Janus kinases JAK1, JAK2, and TYK2. Signaling also involves the transcriptional activators STAT3 and STAT5b (see also: STAT proteins) were specifically activated through the gp130-OSM-R-beta type II heterocomplex. The signaling pathway differences observed between the common type I LIF/OSM receptor and the specific type II OSM receptor might explain some of the bioactivities specifically displayed by OSM. Oncostatin M inhibits the growth of several tumor cell lines (A375 melanoma, lung carcinomas). The antiproliferative activity of oncostatin M for some cell lines is synergised by TGF-beta and IFN-gamma. It promotes the growth of human fibroblasts, vascular smooth muscle cells, and some normal cell lines. Oncostatin can inhibit the proliferation of murine M1 myeloid leukemic cells and induces their differentiation into macrophage-like cells, a function shared by LIF, G- CSF, and IL-6.

Recombinant Human PTH

Z100775 100 µg
EUR 85
Description: Parathyroid hormone is a circulating hormone that acts as the central regulator of calcium metabolism by directly targeting bone, kidney, and intestine. The classical concept of PTH action is that it regulates serum calcium levels by stimulating bone resorption. However, intermittent administration of PTH selectively stimulates bone formation. It is now known that PTH binds to its receptor PTH1R, and activates the G protein alpha subunits. Besides PKA and PKC activation, PTH also regulates MAPKs including p42/p44 ERKs, p38, and c-Jun N-terminal kinase subtypes.

Recombinant Human PTH

Z100777 1.0 mg
EUR 705
Description: Parathyroid hormone is a circulating hormone that acts as the central regulator of calcium metabolism by directly targeting bone, kidney, and intestine. The classical concept of PTH action is that it regulates serum calcium levels by stimulating bone resorption. However, intermittent administration of PTH selectively stimulates bone formation. It is now known that PTH binds to its receptor PTH1R, and activates the G protein alpha subunits. Besides PKA and PKC activation, PTH also regulates MAPKs including p42/p44 ERKs, p38, and c-Jun N-terminal kinase subtypes.

Recombinant Human PTH

Z100779 2.0 mg
EUR 1140
Description: Parathyroid hormone is a circulating hormone that acts as the central regulator of calcium metabolism by directly targeting bone, kidney, and intestine. The classical concept of PTH action is that it regulates serum calcium levels by stimulating bone resorption. However, intermittent administration of PTH selectively stimulates bone formation. It is now known that PTH binds to its receptor PTH1R, and activates the G protein alpha subunits. Besides PKA and PKC activation, PTH also regulates MAPKs including p42/p44 ERKs, p38, and c-Jun N-terminal kinase subtypes.

Recombinant Human SCF

Z100815 10 µg
EUR 115
Description: SCF is a stromal cell-derived cytokine synthesized by fibroblasts and other cell types. SCF promotes proliferation and early differentiation of cells at the level of multipotent stem cells. It has been suggested that SCF is essential for optimal production of various hematopoietic lineages, mainly because of its ability to prevent apoptosis when co-stimulated with other cytokines. The receptor for SCF, designated SCFR (CD117) is the oncogene designated as KIT. The biological activities of SCF are considerably synergised by colony stimulating factors; GM-CSF and G-CSF, and by IL7, EPO and some other growth and differentiation factors. In combination with IL7, SCF stimulates the proliferation of pre-B cells. SCF is also a potent chemoattractant for cells expressing the kit receptor. Recombinant Human SCF is a monomeric protein that contains intra-chain disulfide bonds.

Recombinant Human SCF

Z100817 100 µg
EUR 480
Description: SCF is a stromal cell-derived cytokine synthesized by fibroblasts and other cell types. SCF promotes proliferation and early differentiation of cells at the level of multipotent stem cells. It has been suggested that SCF is essential for optimal production of various hematopoietic lineages, mainly because of its ability to prevent apoptosis when co-stimulated with other cytokines. The receptor for SCF, designated SCFR (CD117) is the oncogene designated as KIT. The biological activities of SCF are considerably synergised by colony stimulating factors; GM-CSF and G-CSF, and by IL7, EPO and some other growth and differentiation factors. In combination with IL7, SCF stimulates the proliferation of pre-B cells. SCF is also a potent chemoattractant for cells expressing the kit receptor. Recombinant Human SCF is a monomeric protein that contains intra-chain disulfide bonds.

Recombinant Human SCF

Z100819 10 x 100 µg (Z100817 x 10)
EUR 2350
Description: SCF is a stromal cell-derived cytokine synthesized by fibroblasts and other cell types. SCF promotes proliferation and early differentiation of cells at the level of multipotential stem cells. It has been suggested that SCF is essential for optimal production of various hematopoietic lineages, mainly because of its ability to prevent apoptosis when it co-stimulates with other cytokines. The receptor for SCF, designated SCFR(CD117), is the oncogene designated as KIT. The biological activities of SCF are synergised considerably by colony stimulating factors GM-CSF and G-CSF, and also by IL-7, Epo and some other growth and differentiation factors. In combination with IL-7, SCF stimulates the proliferation of pre-B cells. SCF is also a potent chemoattractant for cells (see also: Chemotaxis), for example, mast cells expressing the kit receptor. One response to SCF in these cells is a characteristic rearrangement of the actin filaments of the cytoskeleton.

Recombinant Human TNF

Z100855 50 µg
EUR 85
Description: Tumor Necrosis Factor is secreted by macrophages, monocytes, neutrophils, T cells, natural killer cells following their stimulation by bacterial lipopolysaccharides although cells expressing CD8(+) secrete little or no TNF-alpha. In addition, TNF is secreted by peripheral neutrophilic granulocytes and by a number of transformed cell lines that include those of astrocytes, microglial cells, smooth muscle cells and fibroblasts. Human milk also contains this factor. The synthesis of TNF-alpha is induced by many different stimuli including interferons, IL2, GM-CSF, SP, Bradykinin, Immune complexes, inhibitors of cyclooxygenase and platelet activating factor. TNF-alpha shares approximately 30% homology with TNF-beta. Human TNF-alpha is a non-glycosylated protein of 17.6 kDa.

Recombinant Human TNF

Z100857 100 µg
EUR 135
Description: Tumor Necrosis Factor is secreted by macrophages, monocytes, neutrophils, T cells, natural killer cells following their stimulation by bacterial lipopolysaccharides although cells expressing CD8(+) secrete little or no TNF-alpha. In addition, TNF is secreted by peripheral neutrophilic granulocytes and by a number of transformed cell lines that include those of astrocytes, microglial cells, smooth muscle cells and fibroblasts. Human milk also contains this factor. The synthesis of TNF-alpha is induced by many different stimuli including interferons, IL2, GM-CSF, SP, Bradykinin, Immune complexes, inhibitors of cyclooxygenase and platelet activating factor. TNF-alpha shares approximately 30% homology with TNF-beta. Human TNF-alpha is a non-glycosylated protein of 17.6 kDa.

Recombinant Human TNF

Z100859 1.0 mg
EUR 630
Description: Tumor Necrosis Factor is secreted by macrophages, monocytes, neutrophils, T cells, natural killer cells following their stimulation by bacterial lipopolysaccharides. Cells expressing CD4 secrete TNF-alpha while CD8(+) cells secrete little or no TNF-alpha. Stimulated peripheral neutrophilic granulocytes but also unstimulated cells and also a number of transformed cell lines, astrocytes, microglial cells, smooth muscle cells, and fibroblasts also secrete TNF. Human milk also contains this factor. The synthesis of TNF-alpha is induced by many different stimuli including interferons, IL-2, GM-CSF, SP, Bradykinin, Immune complexes, inhibitors of cyclooxygenase and PAF (platelet activating factor). Human TNF-alpha is a non-glycosylated protein of 17 kDa and a length of 157 amino acids. Murine TNF-alpha is N-glycosylated. Homology with TNF-beta is approximately 30%. TNF-alpha forms dimers and trimers.

Recombinant Human LTA

Z100865 20 µg
EUR 85
Description: TNF-beta is a potent mediator of inflammatory and immune responses. It belongs to the TNF family of ligands and signals through TNFR1 and TNFR2. TNF-beta is produced by activated T and B lymphocytes, and has similar activities to TNF-alpha. Like TNF-alpha, TNF-beta is involved in the regulation of various biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, and neurotransmission. TNF-beta is secreted as a soluble polypeptide, but can form heterotrimers with lymphotoxin-beta, which effectively anchors the TNF-beta to the cell surface. TNF-beta is cytotoxic to a wide range of tumor cells.

Recombinant Human LTA

Z100867 100 µg
EUR 345
Description: TNF-beta is a potent mediator of inflammatory and immune responses. It belongs to the TNF family of ligands and signals through TNFR1 and TNFR2. TNF-beta is produced by activated T and B lymphocytes, and has similar activities to TNF-alpha. Like TNF-alpha, TNF-beta is involved in the regulation of various biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, and neurotransmission. TNF-beta is secreted as a soluble polypeptide, but can form heterotrimers with lymphotoxin-beta, which effectively anchors the TNF-beta to the cell surface. TNF-beta is cytotoxic to a wide range of tumor cells.

Recombinant Human LTA

Z100869 1.0 mg
EUR 1500
Description: TNF-beta is a potent mediator of inflammatory and immune responses. It belongs to the TNF family of ligands and signals through TNFR1 and TNFR2. TNF-beta is produced by activated T and B lymphocytes, and has similar activities to TNF-alpha. Like TNF-alpha, TNF-beta is involved in the regulation of various biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, and neurotransmission. TNF-beta is secreted as a soluble polypeptide, but can form heterotrimers with lymphotoxin-beta, which effectively anchors the TNF-beta to the cell surface. TNF-beta is cytotoxic to a wide range of tumor cells.

Recombinant Human MIF

Z100915 25 µg
EUR 75
Description: Macrophage Migration Inhibitory Factor (MIF) is a proinflammatory cytokine. MIF is involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.

Recombinant Human MIF

Z100917 100 µg
EUR 255
Description: Macrophage Migration Inhibitory Factor (MIF) is a proinflammatory cytokine. MIF is involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.

Recombinant Human MIF

Z100919 1.0 mg
EUR 1150
Description: Macrophage Migration Inhibitory Factor (MIF) is a proinflammatory cytokine. MIF is involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity.

Recombinant Human IL7

Z100975 10 µg
EUR 85
Description: IL7 is a secreted cytokine of the hemopoietin family that primarily affects early B and T cells and plays an important role in stimulating the proliferation of lymphoid progenitors. IL7 is produced by stromal epithelial cells of the thymus, bone marrow, and intestines. Human and murine IL7 share 60% sequence homology at the primary level and known to exhibit cross species activity. Designated CD127, the human IL7 receptor is a strongly glycosylated membrane protein of 76 kDa. Recombinant Human IL7 is a 17.7 kDa, non-glycosylated protein.

Recombinant Human IL7

Z100977 100 µg
EUR 470
Description: IL7 is a secreted cytokine of the hemopoietin family that primarily affects early B and T cells and plays an important role in stimulating the proliferation of lymphoid progenitors. IL7 is produced by stromal epithelial cells of the thymus, bone marrow, and intestines. Human and murine IL7 share 60% sequence homology at the primary level and known to exhibit cross species activity. Designated CD127, the human IL7 receptor is a strongly glycosylated membrane protein of 76 kDa. Recombinant Human IL7 is a 17.7 kDa, non-glycosylated protein.

Recombinant Human IL7

Z100979 1.0 mg
EUR 6900
Description: IL7 is secreted constitutively into the conditioned medium of adherent bone marrow stromal cells and thymic cells. Mouse and human keratinocytes have been shown also to express and secrete IL7.Human (152 amino acids; 17.4 kDa) and murine IL7 (129 amino acids) show 60 % sequence homology at the protein level. The human IL7 receptor is an integral strongly glycosylated membrane proteins of 76 kDa expressed on activated T-cells. This receptor has been designated as CD127. IL7 receptors are expressed on pre-B-cells and their progenitors. They are not expressed on mature B-cells. IL7 receptors are expressed also on bone marrow macrophages. Functional IL7 receptors are found on the cell surface of multiphenotypic, biphenotypic, and immature lymphoid progenitors of B- cells with the gene arrangement of the heavy immunoglobulin chain such as those observed in the germ line

Recombinant Human IL2

Z101235 50 µg
EUR 235
Description: IL-2 is produced mainly by T cells expressing the surface antigen CD4 following cell activation by mitogens or allogen. Interleukin-2 (IL-2) has multiple, sometimes opposing, functions during an inflammatory response. It is a potent inducer of T cell proliferation. Th1 and Th2 effector T cell differentiation and provides T cells with a long-lasting competitive advantage resulting in the optimal survival and function of memory cells. In a regulatory role, IL-2 is important for the development, survival, and function of regulatory T cells, it enhances Fas- mediated activation-induced cell death, and it inhibits the development of inflammatory Th17 cells. Thus, in its dual and contrasting functions, IL-2 contributes to both the induction and the termination of inflammatory immune responses.

Recombinant Human TNF

Z101385 50 µg
EUR 510
Description: Tumor Necrosis Factor is secreted by macrophages, monocytes, neutrophils, T cells, natural killer cells following their stimulation by bacterial lipopolysaccharides. Cells expressing CD4 secrete TNF-alpha while CD8(+) cells secrete little or no TNF-alpha. Stimulated peripheral neutrophilic granulocytes but also unstimulated cells and also a number of transformed cell lines, astrocytes, microglial cells, smooth muscle cells, and fibroblasts also secrete TNF. Human milk also contains this factor. The synthesis of TNF-alpha is induced by many different stimuli including interferons, IL-2, GM-CSF, SP, Bradykinin, immune complexes, inhibitors of cyclooxygenase, and PAF (platelet activating factor). Human TNF-alpha is a non-glycosylated protein of 17 kDa and a length of 157 amino acids. Murine TNF-alpha is N-glycosylated. Homology with TNF-beta is approximately 30%. TNF-alpha forms dimers and trimers.

Recombinant Human EPO

Z101435 50 µg
EUR 75
Description: EPO is predominantly synthesized and secreted by tubular and juxtatubular capillary, endothelial, and interstitial cells of the kidney. Approximately 10-15% of the total amount of EPO comes from extrarenal sources and is predominantly produced by hepatocytes and Kupffer cells of the liver. Approximately 40% of the molecular mass of EPO is due to its glycosylation. Glycosylation is an important factor determining the pharmacokinetic behaviour of EPO in vivo. Non-glycosylated Epo has an extremely short biological half life. Recombinant Human EPO is a glycosylated protein that runs at approximately 35 kDa owing to its glycosylation.

Recombinant Human EPO

Z101437 500 µg
EUR 360
Description: EPO is predominantly synthesized and secreted by tubular and juxtatubular capillary, endothelial, and interstitial cells of the kidney. Approximately 10-15% of the total amount of Epo comes from extrarenal sources and is predominantly produced by hepatocytes and Kupffer cells of the liver. Approximately 40% of the molecular mass of Epo is due to its glycosylation. Glycosylation is an important factor determining the pharmacokinetic behavior of Epo in vivo. Non-glycosylated Epo has an extremely short biological half life. It still binds to its receptor and may even have a higher specific activity in vitro.

Recombinant Human EPO

Z101439 1.0 mg
EUR 660
Description: EPO is predominantly synthesized and secreted by tubular and juxtatubular capillary, endothelial, and interstitial cells of the kidney. Approximately 10-15% of the total amount of Epo comes from extrarenal sources and is predominantly produced by hepatocytes and Kupffer cells of the liver. Approximately 40% of the molecular mass of Epo is due to its glycosylation. Glycosylation is an important factor determining the pharmacokinetic behavior of Epo in vivo. Non-glycosylated Epo has an extremely short biological half life. It still binds to its receptor and may even have a higher specific activity in vitro.

Recombinant Human SHH

Z101675 30 µg
EUR 105
Description: Highly conserved proteins, members of the Hedgehog family are widely represented throughout the animal kingdom. The three known mammalian Hedgehog proteins; Sonic (SHH), Desert (DHH) and Indian (IHH) hedgehog share a high degree of sequence and structural identity. SHH is specifically known to be expressed in fetal intestine, liver, lung and kidney. Recombinant Human SHH represents the N-product (N-terminal domain with Cys24 substituted by an Ile-Val-Ile sequence) which retains all the known signalling capabilities.

Recombinant Human SHH

Z101677 100 µg
EUR 215
Description: Highly conserved proteins, members of the Hedgehog family are widely represented throughout the animal kingdom. The three known mammalian Hedgehog proteins; Sonic (SHH), Desert (DHH) and Indian (IHH) hedgehog share a high degree of sequence and structural identity. SHH is specifically known to be expressed in fetal intestine, liver, lung and kidney. Recombinant Human SHH represents the N-product (N-terminal domain with Cys24 substituted by an Ile-Val-Ile sequence) which retains all the known signalling capabilities.

Recombinant Human SHH

Z101679 1.0 mg
EUR 1150
Description: Highly conserved proteins, members of the Hedgehog family are widely represented throughout the animal kingdom. The three known mammalian Hedgehog proteins; Sonic (SHH), Desert (DHH) and Indian (IHH) hedgehog share a high degree of sequence and structural identity. SHH is specifically known to be expressed in fetal intestine, liver, lung and kidney. Recombinant Human SHH represents the N-product (N-terminal domain with Cys24 substituted by an Ile-Val-Ile sequence) which retains all the known signalling capabilities.

Recombinant Human DHH

Z101695 50 µg
EUR 85
Description: The Desert Hedgehog protein is one of the three Hedgehog family proteins that is highly conserved and plays a role in many developmental processes in animals. DHH become biologically active following its autocatalytic cleavage. There is a high degree of residue homology between Sonic Hedgehog (SHH), Indian Hedgehog (IHH), and DHH. Despite their individual levels of expression and unique biological roles, the Hedgehog family members all use the same signalling pathway, and therefore, may be used interchangeably for some experimental purposes.

Recombinant Human DHH

Z101697 250 µg
EUR 375
Description: The Desert Hedgehog protein is one of the three Hedgehog family proteins that is highly conserved and plays a role in many developmental processes in animals. DHH become biologically active following its autocatalytic cleavage. There is a high degree of residue homology between Sonic Hedgehog (SHH), Indian Hedgehog (IHH), and DHH. Despite their individual levels of expression and unique biological roles, the Hedgehog family members all use the same signalling pathway, and therefore, may be used interchangeably for some experimental purposes.

Recombinant Human DHH

Z101699 1.0 mg
EUR 1320
Description: The Desert Hedgehog protein is one of the three Hedgehog family proteins that is highly conserved and plays a role in many developmental processes in animals. DHH become biologically active following its autocatalytic cleavage. There is a high degree of residue homology between Sonic Hedgehog (SHH), Indian Hedgehog (IHH), and DHH. Despite their individual levels of expression and unique biological roles, the Hedgehog family members all use the same signalling pathway, and therefore, may be used interchangeably for some experimental purposes.

Recombinant Human MIA

Z102045 20 µg
EUR 85
Description: MIA is a secreted, regulatory protein produced mainly by chondrocytes and malignant melanoma cells. This protein induces the metastasis of cancer cells by indirectly causing the detachment of melanoma cells from the surrounding extracellular matrix. MIA levels are now measured and used as a diagnostic tool for melanoma metastasis and rheumatoid arthritis.

Recombinant Human MIA

Z102049 1.0 mg
EUR 3195
Description: MIA is a secreted, regulatory protein produced mainly by chondrocytes and malignant melanoma cells. This protein induces the metastasis of cancer cells by indirectly causing the detachment of melanoma cells from the surrounding extracellular matrix. MIA levels are now measured and used as a diagnostic tool for melanoma metastasis and rheumatoid arthritis.

Recombinant Human IL9

Z102475 10 µg
EUR 195
Description: Interleukin 9 (IL9) is an immunoregulatory cytokine belonging to the IL-7/IL-9 cytokine family. Commonly produced by TH17 cells, IL9 acts as a hematopoietic cell regulator by preventing apoptosis and stimulates cell proliferation of T lymphocytes, erythroid cells, and mast cells. It binds to the IL9 receptor (IL9R) to activate different signal transducer and activator (STAT) proteins. It also supports IL2 and IL4 independent growth of helper T-cells and affects TH17 and Tregs through STAT3 and STAT5 signalling activation. Furthermore, IL9 has been found to be a candidate gene for asthma as its presence determines the pathogenesis of bronchial hyper-responsiveness. Although human and mouse IL9 share a 56% amino acid identity, human IL9 is not active on mouse cells and can be found to inhibit melanoma growth in mice.

Recombinant Human IL9

Z102479 1.0 mg
EUR 6900
Description: Interleukin 9 (IL9) is an immunoregulatory cytokine belonging to the IL-7/IL-9 cytokine family. Commonly produced by TH17 cells, IL9 acts as a hematopoietic cell regulator by preventing apoptosis and stimulates cell proliferation of T lymphocytes, erythroid cells, and mast cells. It binds to the IL9 receptor (IL9R) to activate different signal transducer and activator (STAT) proteins. It also supports IL2 and IL4 independent growth of helper T-cells and affects TH17 and Tregs through STAT3 and STAT5 signalling activation. Furthermore, IL9 has been found to be a candidate gene for asthma as its presence determines the pathogenesis of bronchial hyper-responsiveness. Although human and mouse IL9 share a 56% amino acid identity, human IL9 is not active on mouse cells and can be found to inhibit melanoma growth in mice.

Recombinant Human IL5

Z102625 10 µg
EUR 85
Description: Interleukin 5 (IL5) is a specific hematopoietic growth factor that is responsible for the growth and differentiation of eosinophils. IL5 promotes the growth of immature hematopoietic progenitor cells BFU-E while it causes differentiation of CFU-E the proliferation of which is inhibited by IL5. B cells can be made responsive to IL5 by treatment with suboptimal doses of IL1. Interleukin 5 also promotes the generation of cytotoxic T cells from thymocytes. In thymocytes IL5 induces the expression of high affinity IL2 receptors. Human and mouse IL5 is cross-species reactive. Recombinant Human IL5 is a 26.5 kDa disulfide-linked homodimerized protein.

Recombinant Human HGF

Z102775 10 µg
EUR 195
Description: Hepatocyte growth factor (HGF) is a multifunctional cytokine that was originally described as a mesenchymal-derived factor that regulates cell growth, cell motility, morphogenesis and angiogenesis through activation of its receptor, the transmembrane tyrosine kinase encoded by the c-Met proto-oncogene. HGF and c-Met are often co-expressed or over-expressed in a variety of human malignancies including glioblastoma and medullablastoma. The multifunctional effects of HGF: c-Met signaling in tumor cells are mediated by a network of signal transduction pathways including mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K). HGF consists of two subunits held by a disulfide bond. The alpha subunit (69 kDa) has a length of 440 amino acids and the beta subunit (34 kDa) has a length of 234 amino acids. The beta chain of the factor shows approximately 38% homology at the protein level to the serine protease domain of plasminogen. Recombinant HGF expressed in human 293 cells and has a molecular mass of 70 kDa, lower compared to the Molecular mass for this cytokine expressed in CHO cells which emphasizes the difference in post translational modifications.

Recombinant Human HGF

Z102777 1.0 mg
EUR 6300
Description: Hepatocyte growth factor (HGF) is a multifunctional cytokine that was originally described as a mesenchymal-derived factor that regulates cell growth, cell motility, morphogenesis and angiogenesis through activation of its receptor, the transmembrane tyrosine kinase encoded by the c-Met proto-oncogene. HGF and c-Met are often co-expressed or over-expressed in a variety of human malignancies including glioblastoma and medullablastoma. The multifunctional effects of HGF: c-Met signaling in tumor cells are mediated by a network of signal transduction pathways including mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K). HGF consists of two subunits held by a disulfide bond. The alpha subunit (69 kDa) has a length of 440 amino acids and the beta subunit (34 kDa) has a length of 234 amino acids. The beta chain of the factor shows approximately 38% homology at the protein level to the serine protease domain of plasminogen. Recombinant HGF expressed in human 293 cells and has a molecular mass of 70 kDa, lower compared to the Molecular mass for this cytokine expressed in CHO cells which emphasizes the difference in post translational modifications.

Recombinant Human CSK

Z500098 10 µg
EUR 370
Description: CSK is a cytoplasmic tyrosine kinase that has been shown to downregulate the tyrosine kinase activity of the c-src through tyrosine phosphorylation of the c-src carboxy terminus . A yeast 2-hybrid system has been used to identify proteins associated with CSK. The Src homology-3 (SH3) domain of CSK associates with a proline-rich region of PEP, a protein-tyrosine phosphatase expressed in hemopoietic cells . This association is highly specific and it is speculated that PEP may be an effector and/or regulator of CSK in T cells and other hemopoietic cells.

Recombinant Human BMX

Z500413 10 µg
EUR 370
Description: Recombinant full-length human BMX was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. The BMX gene encodes a non-receptor tyrosine kinase, which may play a role in the growth and differentiation of hematopoietic cells. The BMX gene is located on chromosomal band Xp22.2 between the DXS197 and DXS207 loci. Interestingly, chromosome X also contains the closest relative of BMX, the BTK gene, implicated in X-linked agammaglobulinemia. BMX is found to induce activation of the Stat signalling pathway.

Recombinant Human IA2

DAG-WT1345 1 mg
EUR 1460
Description: Recombinant

Recombinant Human GAD

DAG-WT1346 1 mg
EUR 1460
Description: Recombinant

CTAGE1 Recombinant Protein (Human) (Recombinant- Tag)

RP008266 100 ug Ask for price

CTAGE5 Recombinant Protein (Human) (Recombinant- Tag)

RP008269 100 ug Ask for price

CTAGEP Recombinant Protein (Human) (Recombinant- Tag)

RP008275 100 ug Ask for price

TAGLN2 Recombinant Protein (Human) (Recombinant Tag)

RP030889 100 ug Ask for price

TAGLN2 Recombinant Protein (Human) (Recombinant Tag)

RP030892 100 ug Ask for price

TAGLN3 Recombinant Protein (Human) (Recombinant Tag)

RP030895 100 ug Ask for price

CTAGE4 Recombinant Protein (Human) (Recombinant- Tag)

RP053403 100 ug Ask for price

CTAGE8 Recombinant Protein (Human) (Recombinant- Tag)

RP053409 100 ug Ask for price

CTAGE9 Recombinant Protein (Human) (Recombinant- Tag)

RP053412 100 ug Ask for price

CTAG1A Recombinant Protein (Human) (Recombinant- Tag)

RP038332 100 ug Ask for price

CTAG1B Recombinant Protein (Human) (Recombinant- Tag)

RP038335 100 ug Ask for price

CTAGE5 Recombinant Protein (Human) (Recombinant- Tag)

RP038338 100 ug Ask for price

Recombinant Human AREG

EPT131 10ug
EUR 71.4
Description: Recombinant Human Amphiregulin is produced by our E.coli expression system and the target gene encoding Ser101-Lys198 is expressed.

Recombinant Human GDNF

EPT143 10ug
EUR 167.4
Description: Recombinant Human Glial Cell Line-Derived Neurotrophic Factor is produced by our E.coli expression system and the target gene encoding Ser78-Ile211 is expressed.

Recombinant Human CCL5

EPT210 10ug
EUR 131.4
Description: Recombinant Human C-C Motif Chemokine 5 is produced by our E.coli expression system and the target gene encoding Ser24-Ser91 is expressed.

RECOMBINANT HUMAN CTGF

GWB-2A2250 0.02 mg Ask for price

RECOMBINANT HUMAN CNTF

GWB-1475FD 0.02 mg Ask for price

In short, these findings indicate that leptin may be the main molecule that mediates the effects of adipocytes in inflammatory cells such as basophiles by binding LEPR and activating cellular functions, which may worsen allergic inflammation.

Related Post

Leave A Comment